WHAT WE DO

 

We bring commitment, an authentic approach and the agility and sophistication, of a boutique executive search firm. Our focus is centered around identifying and integrating executives and leaders within multinational organizations to enhance performance, profitability and culture. Each of our unique clients benefit from a partnership built on trust, communication and the ability to develop solutions to their talent needs around the world.

 

 

Continents Served Worldwide

Years of Talent Experience

Placements


EXECUTIVE & LEADERSHIP PLACEMENT

Our areas of expertise include Boards, CEO, Executive and Leadership search within the following functional disciplines across the US, Asia, Europe, Latin America, Canada and the Emerging Markets.

 

Accounting
Business Development

Business Insights & Strategy
Communications
Ethics & Compliance
Finance
Facilities
Government Affairs

Human Resources
Information Technology
Legal
Logistics
Managed Markets
Manufacturing
Marketing
Medical Affairs

Operations
Procurement
R&D
Sales
Security
Supply Chain
Quality


THERAPEUTIC AREAS

 

Diabetes
CNS
Endocrinology
Gastroenterology
Immunology

Oncology
Orphan Disease

Rheumatology
Vaccines
Metabolic Disease

 
Doctor and Patient.jpg

PHARMACEUTICAL

The U.S. Pharmaceutical Industry is one of the world’s most significant national markets holding 30-40 percent of the worldwide market. In 2016, this share was valued at approximately $446 billion U.S. dollars.  Currently, the industry is at an important juncture. Developing remarkable new medicines, preparing for demand and navigating barriers to free trade, is even more critical for organizations and their executives today.


MEDICAL DEVICE

The Medical Device industry is a $390 billion market and will continue to grow in 2017, however cost cutting efforts will be an opportunity for organizations and their leaders. The wearable device revenues will outpace the remainder of the medical device market, while cybersecurity threats will become more of a concern. Strong leadership implementing fully optimized offerings and scalable M&A decisions will also continue to be a growing need within this industry.


LIFE SCIENCES

All Life Sciences industry growth is closely tied to global healthcare expenditures. Biotechnology, pharmaceuticals, biomedical technologies, life systems technologies, nutraceuticals, cosmeceuticals, and environmental populations are heavily impacted by pricing pressures, regulatory changes, and emerging innovations. Adapting to potential downstream impacts and uncertainty in the regulatory landscape, will continue to be imperative priorities for executives managing these outcomes.


HEALTHCARE

The US is a $9.59 trillion global healthcare market in both developed and developing nations. With rising healthcare cost, gaps in service and increasing demand for wellness, new providers and virtual care is on the rise. Bringing continued care to patients and innovative talent within this segment will result in favorable outcomes. The longer-term impact within this everchanging industry will be shaped by its leaders as they create more value for patients, healthcare payers and providers.